Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trials In Progress
447 Interim results of a phase 1 study of the novel engineered toxin body TAK-169 in patients with relapsed or refractory multiple myeloma
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 447 Interim results of a phase 1 study of the novel engineered toxin body TAK-169 in patients with relapsed or refractory multiple myeloma